Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
| ▸ | TIPARP | Q7Z3E1 | 2/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 7/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.38 |
| ▸ | NAMPT | P43490 | 7/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18630000 | 0.84 | SIGMAR1 (0.50) | SIGMAR1CHRNB2CHRNA4TIPARPHDAC2 | |
| SCHEMBL15025467 | 0.84 | SIGMAR1 (0.50) | SIGMAR1CHRNB2CHRNA4TIPARPNAMPT | |
| SCHEMBL15890216 | 0.77 | SIGMAR1 (0.46) | SIGMAR1CHRNB2CHRNA4TIPARPHDAC2 | |
| SCHEMBL28923808 | 0.77 | SIGMAR1 (0.46) | SIGMAR1CHRNB2CHRNA4TIPARPHDAC2 | |
| SCHEMBL256354 | 0.77 | SIGMAR1 (0.46) | SIGMAR1CHRNB2CHRNA4TIPARPNAMPT | |
| SCHEMBL20159100 | 0.74 | SIGMAR1 (0.59) | SIGMAR1CHRNB2CHRNA4NAMPT | |
| SCHEMBL29690628 | 0.74 | HDAC2 (0.49) | HDAC2HDAC1NAMPT | |
| SCHEMBL6120302 | 0.74 | HDAC2 (0.49) | HDAC2HDAC1NAMPT | |
| Hydrochloric Acid SCHEMBL28461524 | 0.72 | HDAC2 (0.48) | HDAC2HDAC1NAMPT | |
| Hydrochloric Acid SCHEMBL28011425 | 0.72 | HDAC2 (0.48) | HDAC2HDAC1NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018086703-A1 | DIHYDROPYRIDAZINONES SUBSTITUTED WITH PHENYLUREAS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2018-05-17 | — | — | WO | disclosed |
| EP-2788333-B1 | 1,2,4-TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA | BOEHRINGER INGELHEIM INT (DE) | 2016-03-23 | — | — | EP | disclosed |
| WO-2013083741-A1 | 1,2,4 -TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-06-13 | — | — | WO | disclosed |
| WO-2013026163-A1 | HEPATITIS C INHIBITOR COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-02-28 | — | — | WO | disclosed |